Skip to main content

2021 PDA/FDA Joint Regulatory Conference Main banner

Tweets by 2021 PDA/FDA Joint Regulatory Conference

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

G
Gabriele, Mirko

ThermoFisher Scientific
Live Q&A (B2)
Mirko Gabriele
Favorite
Risk Management in Technology Transfer: The Receiving Site Perspective
Mirko Gabriele
Favorite
Gaines, Victor (Ray)

U.S. FDA
Live Q&A (A1)
Victor (Ray) Gaines
Favorite
Ganjawala, Milind

U.S. FDA
Live Q&A (A4)
Milind Ganjawala
Favorite
Process Validation Lifecycle: 10 Years in Review
Milind Ganjawala
Favorite
Godwin, Francis

U.S. FDA
CDER/OC/OMQ Update
Francis Godwin
Favorite
Closing Remarks
Francis Godwin
Favorite
Live Q&A (P1-Cavazzoni)
Francis Godwin
Favorite
Live Q&A (P1-Cowley)
Francis Godwin
Favorite
Live Q&A (P4)
Francis Godwin
Favorite
Plenary 1: Opening Plenary
Francis Godwin
Favorite
Welcome and Opening Remarks from PDA Leadership and Conference Co-Chairs
Francis Godwin
Favorite
Gooen Bizjak, CDR Tara

U.S. FDA
A4: Process Validation Lifecycle: 10 Years in Review
CDR Tara Gooen Bizjak
Favorite
Inspection-Based Live Q&A
CDR Tara Gooen Bizjak
Favorite
Inspection-Based Panel Discussion
CDR Tara Gooen Bizjak
Favorite
Live Q&A (A4)
CDR Tara Gooen Bizjak
Favorite
Live Q&A (B2)
CDR Tara Gooen Bizjak
Favorite
Live Q&A (B3)
CDR Tara Gooen Bizjak
Favorite
Manufacturing During and After the Pandemic: A Regulatory Perspective
CDR Tara Gooen Bizjak
Favorite
Guilfoyle, Dennis

Johnson & Johnson
Do Environmental Isolates have a Role in Method Suitability and Growth Promotion in the Microbiology Laboratory?
Dennis Guilfoyle
Favorite
Live Q&A (ST3)
Dennis Guilfoyle
Favorite
Gutierrez Lugo, Maria

U.S. FDA
Live Q&A (C2)
Maria Gutierrez Lugo
Favorite
Regulatory Approaches to Accelerated SARS-CoV-2 Neutralizing Antibody Development
Maria Gutierrez Lugo
Favorite